Case Study 2: The GLP-1 Battles (Semaglutide & Tirzepatide) The strategic principles pioneered in the Azurity case have been deployed on a massive scale in the recent, high-profile conflicts over compounded GLP-1 agonists like semaglutide (the API in Ozempic and Wegovy) and tirzepatide (the API in Mounjaro and Zepbound)
It is suitable for athletes, active individuals, and anyone undergoing programs focused on restoring musculoskeletal health and functional resilience.
Tirzepatide is helpful but may only be necessary for a while if you can adopt lifestyle changes and continue to use them after you stop tirzepatide
and 3, normal strong response
Medicare: Contrary to the old Medicare doesnt cover weight loss drugs rule of thumb, a Medicare GLP-1 Bridge pilot begins July 1, 2026 with a $50 monthly copay for eligible enrollees
For vegans and vegetarians that dont eat meat or dairy, it can be a challenge